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Summary
The present study was conducted to develop and validate 
a  specific  radioimmunoassay  system  for  measurement 
of  bovine  chymosin  B  (bChyB)  concentrations  in  plasma 
samples. Bovine ChyB was used for immunization of rabbits 
and  as  standard  and  tracer.  Chymosin  B  concentrations 
were  measured  in  plasma  samples  from  two  groups  of 
calves  (Group  1:  calves  sampled  from  birth  to  24  hours; 
Group 2: calves sampled from Day 1 to 21 after birth) and 
from  one  cow  during  the  peri-partum  period.  Detection 
limit  of  the  assay  was  9.0  ng/ml.  Recovery  was  higher 
than 89.3%. Repeatability and reproducibility ranged from 
1.52% to 5.23% and from 1.52% to 12.57% respectively. No 
cross-reaction was found with pepsinogen A from bovine, 
porcine or human origins. In Group 1, bChyB concentrations 
increased from 47.3 ± 45.1 ng/ml (5 min after birth) to 325.5 ± 
161.2 ng/ml (12 hours after birth), then no significant change 
was observed till 24 hours after birth (293.0 ± 161.5 ng/ml). 
In Group 2, concentrations decreased from Day 1 (455.3 ± 
191.1 ng/ml) to Day 21 (117.9 ± 85.1 ng/ml). In adult cow, 
mean concentration was 136.0 ± 32.3 ng/ml. In conclusion, 
bChyB is able to cross the stomach basal membrane and 
to reach the blood circulation at detectable levels in both 
young calves and adult cows.
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Résumé
Développement d’un dosage radioimmunologique de la 
chymosine B bovine
La présente étude a été menée pour développer et valider 
un  système  de  dosage  radioimmunologique  spécifique 
pour  la  détection  de  la  chymosine  B  (bChyB)  dans  des 
échantillons de plasma. De la chymosine B a été utilisée pour 
l’immunisation des lapins et la production de standard et 
de traceur. Les concentrations de bChyB ont été mesurées 
dans le plasma chez deux groupes de veaux (Groupe 1: de la 
naissance à 24 heures, Groupe 2: du jour 1 au jour 21 après 
la naissance) et chez une vache gestante durant la période 
péri partum. La limite de détection du dosage était de 9 ng/
ml et l’exactitude était supérieure à 89,3%. La  répétabilité 
et  la  reproductibilité  étaient  comprises  entre  1,52%  et 
5,23%, et entre 1,52% et 12,57% respectivement. Aucune 
réaction croisée n’a été détectée avec les pepsinogènes A 
d’origine bovine, porcine ou humaine. Chez le Groupe 1, 
les concentrations de bChyB augmentent de 47,3 ± 45,1 
ng/ml (5 min après naissance) à 325,5 ± 161,2 ng/ml (12 
heures après naissance), puis aucun changement notable 
n’est observé jusqu’à 24 heures après naissance (293,0 ± 
161,5 ng/ml). Chez le Groupe 2, les valeurs diminuent du 
jour 1 (455,3 ± 191,1 ng/ml) au jour 21 (117,9 ± 85,1 ng/
ml). Chez l’adulte, la concentration moyenne était de 136,0 
± 32,3 ng/ml. En conclusion, le système a permis de doser 
spécifiquement la bChyB dans des échantillons provenant 
de veaux et de vache adulte, démontrant ainsi le passage 
de cette enzyme de la paroi stomacale vers la circulation 
sanguine.
Introduction
The  measurement  of  blood  pepsinogen  is  considered 
to  reflect  the  morphological  and  functional  status  of  the 
gastric mucosa. Pepsinogen assay is used for the indirect 
diagnosis  of  gastrointestinal  diseases  by  Ostertagia  or 
Haemonchus  infestation  in  bovines.  These  worms,  in 
particular Haemonchus, are widespread in both temperate 
and tropical area. They are responsible of important losses in 
animal husbandry by mortality or decrease of milk and meet 
production.  Especially  in  tropical  area,  Haemonchus  was 
shown being developed high capacity to resist and survive 
in  these  arid  or  sub-arid  countries.  These  helminthosis 
need a better control by indirect diagnosis before the first 
clinical signs of disease. The digestive enzymes such as 
the different forms of pepsinogens and prochymosines are 
good candidate to serve as clinical markers. 
Recently, we purified and developed the radioimmunoassay 
of  bovine  pepsinogen  A  (18).  Pepsinogen  belongs  to 
the  aspartic  proteases  family.  In  this  group  pepsinogen 
A  is  coexisting  with  pepsinogen  C  (progastricsine)  and 
prochymosins A, B and C which are in general considered to 
be specifically found in neonate animals. These molecules 
are constituted by one single polypeptide chain containing 
372 and 381 residues respectively for bovine pepsinogen A 
and bovine prochymosin B. These zymogens are specialized 
in the digestion of dietary proteins and the optimum pH of 
their activation is around 2 and 4.5 respectively. The C form 
of  pepsinogen  have  been  detected  in  bovine,  however, 
probably  due  to  its  relative  low  gastric  expression  when 
compared to pepsinogen A, it was not fully characterized in 
term of amino acid sequence. 
In  human,  pepsinogens  were  also  studied  for  individual 
diagnonis of gastrointestinal pathologies, in 1989, Biemond 
et  al.  (5)  showed  that  the  specific  and  simultaneous 
measurement  of  two  different  forms  of  pepsinogen  (A 
and C), and the use of the ratio A/C, gave more accurate 
informations for the differential diagnosis of gastric ulcers 
and cancers. After this, the scientific literature underlined 
repeatedly  the  greater  interest  of  this  simultaneous 
measurement  of  different  zymogens  in  peripheral  blood. 
So, after the development of the RIA of bovine pepsinogen 
A as indicated above, we complete our approach in order 
to develop an indirect marker for bovine helminthiasis, by 
the  radioimmunoassay  for  a  second  molecule  belonging 
to  the  family  of  the  aspartic  proteases.  Because  of  the 
difficulty to obtain the purified bovine pepsinogen C, bovine 
chymosin B was considered in this work. This protein being 
available from commercial origin (> 90% purity). The RIA 
was validated in plasma, in buffer and then used to measure 
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plasmatic concentrations in newborn and young calves, and 
to investigate the presence of these zymogens in an adult 
cow around parturition. 
Materials and methods
Antisera production
Work on animals was approved by the ethical committee 
from  University  of  Liège  (Authorisation  n.  297).  Antisera 
against bChyB were raised in New Zealand white rabbits 
according to the method of Vaitukaitis et al. (22). During 
two  months,  four  rabbits  (R#814,  R#815,  R#816  and 
R#817) aged between 3 and 5 months received intradermal 
injections (15 days interval) of 500 µg of bChyB (Sigma-
Aldrich Co., St. Louis, MO, USA; Ref. R-4879) dissolved in 
500 µL of phosphate buffer (0.05 M, pH 7.5), and emulsified 
in an equal volume of Freund’s complete adjuvant (Sigma-
Aldrich Co.). Afterwards, rabbits received monthly booster 
doses of bChyB (500 µg) emulsified in Freund’s incomplete 
adjuvant (Difco Laboratories, Detroit 1, USA) over a period 
of six months. The animals were bled two months after the 
first injection and then monthly. The blood samples were 
allowed  to  clot  overnight  at  room  temperature.  The  next 
day, the serum was transferred and centrifuged at 2,500 x g 
for 20 min, then aliquoted and stored at -20 °C till used.
Radiolabeled bChyB (tracer)
The  antigen  was  labeled  according  to  the  chloramine  T 
method (13). For the radio-iodination, 10 µl of bChyB (1 mg/
ml), 10 µL of phosphate buffer (0.5 M, pH 7.5), 10 µL of 
125I-Na (1 mCi) (Amersham Biosciences, Uppsala, Sweden), 
buffered by 10 µl of phosphate buffer (0.5 M, pH 7.5) and 
the oxidation is induced by 10 µL of chloramine T (5.0 mg/
ml) (Sigma-Aldrich Co.). After 1 min of gentle stirring, 10 µL 
metabisulfite (30.0 mg/ml) (Sigma-Aldrich Co.) was added 
to stop the reaction. 
125I-bChyB was purified by gel filtration on a Sephadex G-75 
column (1 x 30 cm) (Amersham Biosciences) equilibrated 
and  eluted  with  the  0.05  M  phosphate  buffer.  Eluted 
aliquots  of  1.0  ml  were  collected,  submitted  onto  a  test 
with  the  antiserum,  and  selected  according  to  the  non-
specific binding value (NSB) and binding/total (B/T) ratio. 
The fractions exhibiting the highest performances in term of 
specific binding were diluted, aliquoted (1.0 ml) and stored 
at -20 °C until used in the RIA procedure.
Second antibody precipitant system
The second antibody was prepared by mixing sheep anti-
rabbit IgG serum with normal rabbit serum (5:1; v:v). This 
solution was incubated for 16 h at 4 °C before used at 1% 
in the precipitation system, which constituents were 0.05 M 
phosphate buffer (pH 7.5), 0.4% BSA, 4% PEG 6000 (VWR, 
Leuven,  Belgium)  and  0.05%  microcristalline  cellulose 
(Merck, Darmstadt, Germany).
Antisera test
The four obtained antisera were serially diluted in the RIA 
buffer (1/10,000, 1/20,000, 1/40,000, 1/80,000, 1/160,000 
and 1/320,000) in order to obtain a tracer-binding ratio in 
the zero standard of approximately 30-50% (B0/T) and non-
specific binding below 2%. For the binding test, 100 µL of 
the initially diluted antiserum, 100 µL of the 125I-bChyB and 
300 µL of the RIA buffer were incubated overnight before 
addition  of  the  second  antibody  precipitation  system, 
centrifugation and count of the pellet radioactivity.
Standard curves
Bovine chymosin B (lyophilized powder) was diluted with 
assay buffer (Phosphate buffer: 0.05 M, pH 7.5, containing 
1 g/L BSA and 5.0 ml of Tween 20 was used throughout 
the procedure) to give standard curves ranging from 4.75 to 
2,500 ng/ml. The RIA was performed at 4 °C in polystyrene 
tubes (75 x 12 mm). Each tube contained 100 µL of standard 
dilution or 100 µL of unknown sample, 100 µL of antiserum 
(R#817) diluted at 1/50,000 (1/250,000 final dilution), and 
100 µL of labeled 125I-bChyB (20,000 cpm). The incubation 
volume was made up to 500 µL by addition of 200 µL of 
RIA  buffer.  In  the  zero  standard  tubes  (B0),  the  standard 
dilution  was  replaced  by  assay  buffer.  The  non-specific 
binding (NSB) tubes contained 400 µL of buffer and 100 
µL of the tracer. All standard and unknown tubes were set 
up in duplicate. The mixture was incubated at 4 °C from 
18 to 24 h. After addition of 1.0 ml of the second antibody 
precipitation system, the mixture was allowed to react at 4 
°C for 1 h. Free and bound bChyB were then separated by 
centrifugation at 3,000 x g for 20 min. The supernatant was 
discarded and the radioactivity of the pellet was determined 
in an automatic gamma counter with a counting efficiency 
of 75% (1261 Multigamma, Wallac, Turku, Finland).
Characteristics of the RIA
To  determine  the  specificity,  available  members  of  the 
aspartic protease family such porcine pepsinogen A (Sigma-
Aldrich  Co.)  and  human  pepsinogen  A  (Sigma-Aldrich 
Co.) were tested in the range from 19.5 to 10,000 ng/ml. 
Purified bovine pepsinogen A (18) was tested in the range 
from 19.5 to 10,000 ng/ml. In addition, different dilutions of 
a plasma sample containing detectable concentrations of 
bChyB were set up in buffer (1/1, 1/2, 1/4, 1/8, 1/16, 1/32 
and  1/64).  The  accuracy  test  was  carried  out  by  adding 
defined concentrations of bChyB (9.5, 39.0, 156.0, 625.0 
and 2,500 ng) to three bovine plasmas containing known 
concentrations. The percentage of recovery was calculated 
as  following  [observed  value  (ng/ml)/expected  value  (ng/
ml)]  x  100.  The  precision  of  the  RIA  was  determined  by 
estimating the intra- and inter-assay coefficients of variation 
(CV).  To  determine  the  intra-assay  CV,  the  same  serum 
was  assayed  10  times  using  the  same  assay.  The  inter-
assay CV was assessed by analyzing the concentrations 
of different sera in five consecutive assays. The sensitivity 
was  determined  by  measuring  the  least  detectable  dose 
(LDD) of bChyB in the developed RIA (20). A set of 20 zero 
binding value were assayed in the same test. The mean and 
the standard deviation (SD) of precipitate counts at zero 
bChyB  concentration  were  calculated.  The  bChyB  value 
that corresponded to the mean count minus two standard 
deviations transposed onto the standard curve was defined 
as the sensitivity of the RIA.
Animals and plasma samples
Two groups (Group 1 and 2) of ten newborn calves each were 
followed. The first group (n= 10) was serially sampled at 5 
minutes, 1 hour, 6 hours, 12 hours and 24 hours after birth. 
The second group (n= 10) was housed in the experimental 
farm  of  the  Faculty  of  Veterinary  Medicine  (University  of 
Liège, Belgium) and sampled when calves were 1, 3, 5, 7, 14 
and 21 days old. In addition, one cow was serially sampled 
during peri-partum period (from day 33 before parturition 
till day 3 after calving). Blood samples were taken from the 
jugular  vein.  Plasma  was  separated  by  centrifugation  at 
2,000 x g and stored at –20 °C until used.
Statistical analysis
The  data  obtained  were  analyzed  with  commercially 
available Microsoft Excel program. The inter- and intra-assay 
CV were calculated as the SD divided by the mean value. 
Mean recoveries at each concentration were calculated as 
a percentage of the expected value. 
Results
Antisera dilution
The dilution curves of the four raised antisera are presented TROPICULTURA
in figure 1. In the presence of excess of antiserum R#817 
(1/10,000),  60.4%  of  labeled  bChyB  was  bound  and  the 
non-specific binding was below 2%. At the same antisera 
excess conditions (1/10,000), the binding ratios of R#814, 
R#815  and  R#816  were  45.25%,  35.71%  and  47.06%, 
respectively. These binding levels point out the fact that the 
performed protocol of immunization had a good efficacy. 
Standard curve and bChyB-RIA validation
The  125I-bChyB  tracer  bound  antiserum  R#817  at  a  high 
final dilution (1:250,000). At this dilution, it bounds 40% of 
tracer with a non-specific bound below 2%. The standard 
inhibition curve ranged from 97.7% to 10.3% binding when 
serial dilutions of bChyB (ranging from 4.75 to 2,500 ng/ml) 
were assayed. The calculated detection limit was 0.9 ng/
tube or 9 ng/ml of plasma. The displacement of the standard 
curve of the RIA is presented in figure 2. 
As  shown  in  figure  3,  no  cross-reaction  was  observed 
in  bChyB  assay  with  either  bovine,  porcine  or  human 
pepsinogen A. Serial dilution of a calf plasma sample showed 
a dose–response curve parallel to the standard curve (Figure 
2). The recovery of the assay ranged from 89.3% to 112.4% 
(Table 1). The coefficients of variation are presented in table 
2. The intra-assay CV ranged from 1.52% to 5.23%, and the 
inter-assay CV from 1.52% to 12.57%.
Figure 1:  Binding ratio after serial dilutions of four antisera (R#814, R#815, R#816 and  R#817) raised against a bovine chymosin B 
preparation.
Figure 2:  Parallelism between bovine chymosin B (bChyB) standard curve and serial dilution of a calf serum sample. The standard curve was 
calculated by the linear scale of B/B0 ratio versus decadic logarithmic of the standard concentration using radiolabeled bChyB. 
B/B0 means tracer bound / tracer bound in zero standard. The serum sample (1/1) was serially diluted at 1/2, 1/4, 1/8; 1/16, 1/32 
and 1/64.
Plasma bChyB concentrations 
In the first group, bChyB was detected at low concentrations 
just after birth (5 minutes) (47.3 ± 45.1 ng/ml). Thereafter, 
the concentrations increased progressively and the highest 
value was observed at 12 hours after birth (325.5 ± 161.2 
ng/ml)  (Figure 4a). In the second group, plasma bChyB 
concentrations showed a gradual decrease with increasing 
age from day 1 (455.3 ± 191.1 ng/ml) to 21 days of age 
(117.9 ± 85.1 ng/ml) (Figure 4b).
Interestingly, bChyB concentrations were also detected in an 
adult cow. In this animal, concentrations ranged from 85 to 
222 ng/ml (136 ± 32.3 ng/ml, for the whole period) indicating 
the presence of a basal detectable bChyB concentrations in 
adult animals.
Discussion
The  present  study  was  performed  to  develop  a  specific 
RIA system for bovine chymosin B, as well as to measure 
its concentration in plasma samples from calves and adult 
animals. The protocol of immunization gave four antisera 
with  high  titers,  allowing  the  choice  of  antiserum  R#817 
for our RIA system. When used at 1:250,000 final dilution, 
this antiserum yielded 40% of specific binding. We recently 
described the development of a bovine pepsinogen A RIA 
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Figure 3: Specificity of the bovine chymosin B radioimmunoassay. The standard curve was calculated by the scale of B/B0 ratio versus 
decadic logarithmic of bChyB concentrations (expressed in ng/ml) using radiolabeled bChyB (125I-bChyB). B/B0 means tracer 
bound / tracer bound in zero standard.
Table 1
Recovery of bovine chymosin B (bChyB) added to three samples containing different concentrations of bChy
Initial serum sample 
bChyB concentration
Amount of bChyB (ng) 
added
Expected bChyB 
concentration (ng/ml)
Observed bChyB 
concentration (ng/ml)
Recovery* 
(%)
1.7 ng/ml        9.5      11.2      10.0   89.3
     39.0      40.7      37.8   92.9
   156.0    157.7    160.1 101.5
   625.0    626.7    570.0   91.0
2,500.0 2,501.7 2,252.9   90.0
25 ng/ml        9.5      34.5      34.7 100.7
     39.0      64.0      69.1 108.0
   156.0    181.0    162.0   89.5
   625.0    650.0    605.3   93.1
2,500.0 2,525.0 2,667.7 105.6
125 ng/ml        9.5    134.5    133.4   99.2
     39.0    164.0    162.8   99.3
   156.0    281.0    271.1   96.5
   625.0    750.0    677.0   90.3
2,500.0 2,625.0 2,951.0 112.4
*(Observed value/Expected value) x 100.
Table 2
Coefficients of variation intra-assay and inter-assay of bovine chymosin B (bChyB) RIA
Bovine sample Intra-assay Inter-assay
bChyB concentrationa CV (%) bChyB concentrationa CV (%)
Sample 1 126.62 ± 1.93 ng/ml
1.52
126.30 ± 1.92 ng/ml
  1.52
Sample 2   30.61 ± 1.52 ng/ml 5.23   25.16 ± 3.16 ng/ml 12.57
aMean ± SD.
system  (19),  the  dilution  of  the  antiserum  being  closely 
related to that of chymosin B (1:250,000). It is a general 
observation that valuable RIA systems are developed with 
antiserum used at high dilution. This assumption is sustained 
by  the  RIA  systems  developed  for  human  pepsinogens 
A and C (5), in which antisera were diluted at 1:200,000 
and  1:300,000,  respectively.  Similar  high  antiserum  titer 
was also reported by Banga-Mboko et al. (3) who used a 
dilution of 1:200,000 for porcine pepsinogen A RIA system. 
Nevertheless, a number of studies reported lower dilution 
levels  of  some  pepsinogen  antisera.  This  was  the  case 
of studies conducted by Samloff and Liebmann (17) who 
reported a final dilution of 1:50,000 for human pepsinogen 
antiserum, and by Nappert et al. (16) who reported a final 
dilution of 1:18,000 for porcine pepsinogen antisera. In the 
same way, Gomes et al. (12) reported the development of 
an ELISA for bovine pepsinogen in which the antiserum was 
diluted at 1:2,000. Advantages related to the use of high 
dilutions of antiserum are the possibility to perform a large 
number of assays with a small volume of the antiserum, and 
a gain in sensitivity and specificity. 
In our RIA protocol, the assay gave a sensitivity of 0.9 ng/
tube (9 ng/ml of plasma) without any pre-incubation step. 
Considering  the  specificity,  no  cross-reaction  was  noted 
with bovine, porcine or human pepsinogen A. This lack of 
cross-reaction point out the high specificity of the present 
assay. The recovery values calculated in the present work 
(89.3%  or  higher)  were  closely  similar  to  those  reported 
for RIA of porcine pepsinogen A (81.7 to 102.3%), human 
pepsinogen  A  (81.3  to  139.5%)  or  bovine  pepsinogen  A 
(85.5 to 103.3%) (3,5,19). The assay showed an intra-assay 
coefficient of variation of 5.23% or lower, and an inter-assay 
variation about 12.57% or lower. The general characteristics 
of the assay in term of sensitivity, specificity, accuracy, intra 
and inter-assay coefficients of variations were satisfactory; 
the  assay  is  therefore  suitable  for  the  measurement  of 
chymosin in bovine plasma. 
To our knowledge, the present study is the first report on 
bChyB  concentrations  in  both  young  calves  and  adult 
cow plasma samples. So, any comparison of the present 
concentrations  with  those  of  other  zymogens  or  those 
obtained in other species has to be interpreted with great 
caution. Just after birth, chymosin concentrations were low, 
they increased between the first and the fourth samples. This 
sharp increase correspond also to the period of colostrum 
consumption.  Surprisingly,  in  our  study,  high  level  of 
chymosin was observed in colostrum whereas no chymosin 
increase  was  detected  in  the  maternal  blood  around 
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parturition. As the concentration of chymosin were also high 
in colostrum (unpublished data), this sharp increase during 
12-24 hours of the calves life remain not clearly explain. Is 
chymosin released in stomach directly reabsorbed in gut 
like for other macromolecules brought by colostrum?; or 
do the colostrum bring an additional amount of chymosin 
that  is  also  reabsorbed?  Moreover  the  possible  role  of 
colostrum chymosin remain unexplained. In this group 1, the 
bChyB plasmatic concentration corresponds to the typical 
suckling  activity  of  very  young  calves,  increased  bChyB 
concentrations being observed 12 hours after birth. These 
results are sustained by the study of Andren and Bjorck (1), 
who demonstrated that in bovine, the mucous neck cells 
and chief cells in the lower base of the gastric gland are 
immunoreactive  to  prochymosin  both  before  and  after 
weaning. The high level of plasma chymosin was observed a 
few time after the first colostrum feeding, this phenomenon 
point out the high level of intestinal absorption before the 
closure occurs 24 hours after birth. From day 1 to 21 after 
birth, an age dependence was observed, calves from group 
2 showing a constant decrease of concentrations from day 
1 to 21 after birth. Interestingly, plasma samples from one 
adult cow also exhibited detectable levels of bChyB. This 
finding shows that in bovine species, from very young till 
Figure 4a:   Evolution of bovine chymosin B concentrations (mean 
± SD) in plasma samples of ten young calves sampled 
from 5 minutes after birth to 24 hours of age.
Figure 4b:   Evolution of bovine chymosin B concentrations (mean 
± SD) in plasma samples of ten calves sampled from 
day 1 to day 21 after birth.
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Conclusion 
The  RIA  showed  good  sensitivity,  specificity,  accuracy 
and  reproducibility.  By  using  the  assay  for  blood  bChyB 
determination, we demonstrate that this zymogen is able 
to  cross  the  basal  gastric  membrane  and  to  reach  the 
general blood circulation in calves, and still detectable in 
adults. Furthermore, bChyB-RIA can be associated to the 
pepsinogen A RIA in the expectation to highlight differential 
diagnosis of gastrointestinal disorders due to parasites as 
Paraphistomum,  Ostertagia  and  Hoemonchus.  The  last 
being frequently responsible of disease in tropical or sub-
tropical area.
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